Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.429, 2003-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Insulin therapy decreases long-term costs in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. :
Access to resources
Recommend
Hospitalisation, complications, raise treatment cost of type 2 diabetes
Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. :
EASD studies shed light on costs of insulin initiation for T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 589, 2009-01 ,pp. :
Insulin glargine superior long-term therapy for type 2 DM in Europe
Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. :
Premixed insulin analogues worth it in the long term in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. :